Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,500
Closed -$74.3K 390
2016
Q4
$74.3K Hold
1,500
0.05% 158
2016
Q3
$78.7K Hold
1,500
0.05% 150
2016
Q2
$67K Hold
1,500
0.05% 150
2016
Q1
$61.4K Hold
1,500
0.05% 140
2015
Q4
$54.8K Hold
1,500
0.04% 146
2015
Q3
$49.3K Hold
1,500
0.04% 151
2015
Q2
$55.6K Hold
1,500
0.04% 145
2015
Q1
$52.5K Hold
1,500
0.04% 150
2014
Q4
$57.1K Hold
1,500
0.04% 143
2014
Q3
$53.2K Hold
1,500
0.04% 143
2014
Q2
$58.6K Hold
1,500
0.04% 141
2014
Q1
$54.6K Hold
1,500
0.04% 141
2013
Q4
$51.9K Hold
1,500
0.04% 144
2013
Q3
$41.9K Hold
1,500
0.03% 150
2013
Q2
$40.4K Buy
+1,500
New +$41.4K 0.03% 147

Other funds holding XYL

West Oak Capital's XYL Position: Q1 2017 in Review

West Oak Capital sold out of Xylem (XYL) in Q1 2017, closing a stake of 1,500 shares — an estimated $74.3K sold.

West Oak Capital first reported a position in XYL in Q2 2013 and held it in 15 quarters. The position peaked at $78.7K in Q3 2016. 547 funds tracked by Wall St. Rank hold XYL as of Q1 2017.

  • West Oak Capital reported no remaining Xylem position as of Q1 2017 after selling out during the quarter.
  • West Oak Capital sold 1,500 Xylem shares in Q1 2017, an estimated $74.3K.
  • West Oak Capital first reported a position in Xylem in Q2 2013 and held it in 15 quarters.
  • West Oak Capital's Xylem position peaked at $78.7K in Q3 2016.
  • 547 funds tracked by Wall St. Rank held Xylem as of Q1 2017.

Based on West Oak Capital's 13F filing for Q1 2017, filed 6 Apr 2017.